Thijn Brummelkamp#
| Membership Number: | 5129 |
| Membership type: | ORDINARY |
| Section: | BIOCHEMISTRY & MOLECULAR BIOLOGY |
| Elected: | 2019 |
| Main Country of Residence: | THE NETHERLANDS |
| Homepage(s): | https://www.nki.nl/divisions/biochemistry/brummelkamp-t-group |
Present and Previous Positions
- 2017 - present managing director (0.2FTE) at Scenic Biotech, Amsterdam
- 2017 - present Professor, Utrecht University
- 2011 - present group leader at the Netherlands Cancer Institute, Amsterdam, The Netherlands
- 2011 - present adjunct principal investigator at the Center for Molecular Medicine, CeMM, in Vienna, Austria
- 2004 - 2010 group leader as Whitehead Fellow at the Whitehead Institute for Biomedical Research, Cambridge MA, United States
- 1998 - 2003 PhD student , supervisor Prof. R. Bernards, Netherlands Cancer Institute. PhD received (cum laude) from Utrecht University (11-11-2003)
Fields of Scholarship
- Genetics
- Cell biology
- Cancer research
- Biomedical research
- Virology
Honours and Awards
- 2003 Ph.D degree, cum laude
- 2003 Antoni Van Leeuwenhoek Award, for contributions on Genomics
- 2004 NVBMB Award (Dutch association for biochemistry and molecular biology)
- 2005 TR35: Elected as one of the world’s top young innovators by Technology Review Magazine
- 2006 Kimmel Scholar Award, Sidney Kimmel Foundation for Cancer Research
- 2012 The Molecular Biosystems Early Career Award
- 2012 Phoenix Pharmazie Wissenschaftspreis
- 2012 ERC starting grant
- 2013 EMBO Gold Medal
- 2014 Elected as EMBO member
- 2015 Ammodo Award from the Royal Netherlands Academy of Arts and Sciences (KNAW)
